Literature DB >> 10607835

Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice.

O Segev1, I Chumakov, Z Nevo, D Givol, L Madar-Shapiro, Y Sheinin, M Weinreb, A Yayon.   

Abstract

Achondroplasia, the most common genetic form of human dwarfism, results from a point mutation (G380R) in the gene for fibroblast growth factor receptor 3 (FGFR-3). Heterozygotes for the mutation share disproportionate, proximal shortening of the limbs, mid-face hypoplasia and relative macrocephaly due to a failure in endochondral ossification. Here we have generated transgenic mice expressing the human mutant FGFR-3 under the transcriptional control of the mouse gene. Mice that are hemizygous for the mutant human gene display disproportionate dwarfism with skeletal phenotypes remarkably similar to those of human achondroplasia. Mice that are homozygous for the transgene suffer from a profound delay in skeletal development and die at birth, similar in that respect to humans homozygous for the achondroplasia mutant gene. Microscopic analysis of long bones demonstrates growth plate morphology compatible with that of human achondroplasia cases, sharing endochondral growth inhibition with restrained chondrocyte proliferation and maturation, penetration of ossification tufts and aberrant vascularization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10607835     DOI: 10.1093/hmg/9.2.249

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  26 in total

1.  Genetic inactivation of ERK1 and ERK2 in chondrocytes promotes bone growth and enlarges the spinal canal.

Authors:  Arjun Sebastian; Takehiko Matsushita; Aya Kawanami; Susan Mackem; Gary E Landreth; Shunichi Murakami
Journal:  J Orthop Res       Date:  2010-10-04       Impact factor: 3.494

Review 2.  Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Authors:  Silvie Foldynova-Trantirkova; William R Wilcox; Pavel Krejci
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

3.  Human stanniocalcin-1 or -2 expressed in mice reduces bone size and severely inhibits cranial intramembranous bone growth.

Authors:  Jennifer Johnston; Yudith Ramos-Valdes; Lee-Anne Stanton; Sadia Ladhani; Frank Beier; Gabriel E Dimattia
Journal:  Transgenic Res       Date:  2010-02-20       Impact factor: 2.788

4.  Roles of FGFR3 during morphogenesis of Meckel's cartilage and mandibular bones.

Authors:  Bruce A Havens; Dimitris Velonis; Mark S Kronenberg; Alex C Lichtler; Bonnie Oliver; Mina Mina
Journal:  Dev Biol       Date:  2008-02-13       Impact factor: 3.582

Review 5.  A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation.

Authors:  Elena Kozhemyakina; Andrew B Lassar; Elazar Zelzer
Journal:  Development       Date:  2015-03-01       Impact factor: 6.868

6.  The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation.

Authors:  E Monsonego-Ornan; R Adar; T Feferman; O Segev; A Yayon
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

7.  FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence.

Authors:  Pavel Krejci; Jirina Prochazkova; Jiri Smutny; Katarina Chlebova; Patricia Lin; Anie Aklian; Vitezslav Bryja; Alois Kozubik; William R Wilcox
Journal:  Bone       Date:  2010-03-31       Impact factor: 4.398

Review 8.  The primary cilium as a signaling nexus for growth plate function and subsequent skeletal development.

Authors:  Emily R Moore; Christopher R Jacobs
Journal:  J Orthop Res       Date:  2017-10-09       Impact factor: 3.494

9.  Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations.

Authors:  Sarah Cormier; Anne-Lise Delezoide; Catherine Benoist-Lasselin; Laurence Legeai-Mallet; Jacky Bonaventure; Caroline Silve
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

10.  Remodeling of chromatin structure within the promoter is important for bmp-2-induced fgfr3 expression.

Authors:  Fenyong Sun; Qiongyu Chen; Songhai Yang; Qiuhui Pan; Ji Ma; Yang Wan; Chih-Hao Chang; An Hong
Journal:  Nucleic Acids Res       Date:  2009-04-28       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.